Intellia Therapeutics, Inc. (NTLA)
10.55
-0.86
(-7.54%)
USD |
NASDAQ |
Nov 12, 16:00
10.79
+0.24
(+2.27%)
After-Hours: 06:39
Intellia Therapeutics Net Income (Quarterly) : -127.48M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -127.48M |
| June 30, 2026 | -106.63M |
| March 31, 2026 | -96.23M |
| December 31, 2025 | -95.79M |
| September 30, 2025 | -101.32M |
| June 30, 2025 | -101.26M |
| March 31, 2025 | -114.33M |
| December 31, 2024 | -128.90M |
| September 30, 2024 | -135.71M |
| June 30, 2024 | -146.98M |
| March 31, 2024 | -107.44M |
| December 31, 2023 | -132.16M |
| September 30, 2023 | -122.22M |
| June 30, 2023 | -123.68M |
| March 31, 2023 | -103.13M |
| December 31, 2022 | -113.41M |
| September 30, 2022 | -113.23M |
| June 30, 2022 | -100.68M |
| March 31, 2022 | -146.87M |
| December 31, 2021 | -81.24M |
| September 30, 2021 | -71.64M |
| June 30, 2021 | -68.81M |
| Date | Value |
|---|---|
| March 31, 2021 | -46.20M |
| December 31, 2020 | -42.19M |
| September 30, 2020 | -27.84M |
| June 30, 2020 | -32.39M |
| March 31, 2020 | -31.81M |
| December 31, 2019 | -28.28M |
| September 30, 2019 | -23.63M |
| June 30, 2019 | -25.68M |
| March 31, 2019 | -21.94M |
| December 31, 2018 | -19.07M |
| September 30, 2018 | -22.70M |
| June 30, 2018 | -22.22M |
| March 31, 2018 | -21.36M |
| December 31, 2017 | -23.96M |
| September 30, 2017 | -15.36M |
| June 30, 2017 | -15.59M |
| March 31, 2017 | -12.63M |
| December 31, 2016 | -10.56M |
| September 30, 2016 | -7.482M |
| June 30, 2016 | -6.90M |
| March 31, 2016 | -6.689M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -- |
| Beam Therapeutics, Inc. | -134.40M |
| Prime Medicine, Inc. | -42.11M |
| 10X Genomics, Inc. | -19.42M |
| Moderna, Inc. | 162.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.163M |
| Total Expenses (Quarterly) | 134.65M |
| EPS Diluted (Quarterly) | -0.9094 |
| Enterprise Value | 1.236B |
| Gross Profit Margin (Quarterly) | 73.15% |
| Profit Margin (Quarterly) | -1.78K% |
| Earnings Yield | -31.72% |
| Normalized Earnings Yield | -30.99 |